Department of Biopharmaceutical Sciences

College of Pharmacy
masthead

Hayat Onyuksel, Ph.D.

Hayat Onyuksel, Ph.D.


Acting Assistant Head, Graduate Studies

Professor, Pharmaceutics and Bioengineering





Contact Information
833 South Wood Street
358 Pharm, MC 865
Chicago, IL 60612-7231
Office: (312) 996-2097
Fax: (312) 996-0098
Email: hayat@uic.edu



Publications (2005-2009)
Targeted Therapy of Rheumatoid Arthritis
 

Sethi V., Rubinstein I., Kuzmis A., Artwohl J., Kastrissios H., and Onyuksel H. Novel, Biocompatible, Disease Modifying Nanomedicine of VIP for Rheumatoid Arthritis. Molecular Pharmaceutics, 10: 728-738, 2013 .

Khaja F.A, Koo O., Onyuksel H. Nanomedicines for Inflammatory Diseases. Methods in Enzymology, Vol 508 Ed. Nejat Duzgunes, Burlington: Academic Press, Chapter 18, pp355-375, 2012.

Koo MY, Rubinstein I, Onyuksel H. Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease Modifying Nanomedicine for Rheumatoid Arthritis. Pharm Res. 28:776-787, 2011. DOI

Onyuksel H, Séjourné F, Suzuki H, Rubinstein I. Human VIP-alpha: a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension. Peptides. 2006 Sep;27(9):2271-5. Epub 2006 Apr 18. DOI

Koo OM, Rubinstein I, Onyuksel H. Camptothecin in Sterically Stabilized Phospholipid Micelles: A Novel Nanomedicine. J. Nanomedicine. 2005 Sep;1:77-84. DOI